These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10440471)

  • 1. Donepezil for Tourette's disorder and ADHD.
    Hoopes SP
    J Clin Psychopharmacol; 1999 Aug; 19(4):381-2. PubMed ID: 10440471
    [No Abstract]   [Full Text] [Related]  

  • 2. An open trial of adjunctive donepezil in attention-deficit/hyperactivity disorder.
    Wilens TE; Waxmonsky J; Scott M; Swezey A; Kwon A; Spencer TJ; Biederman J
    J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):947-55. PubMed ID: 16379515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relevance of donepezil in enhancing learning and memory in special populations: a review of the literature.
    Yoo JH; Valdovinos MG; Williams DC
    J Autism Dev Disord; 2007 Nov; 37(10):1883-901. PubMed ID: 17221321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mania associated with donepezil.
    Benazzi F
    Int J Geriatr Psychiatry; 1998 Nov; 13(11):814-5. PubMed ID: 9850879
    [No Abstract]   [Full Text] [Related]  

  • 5. Donepezil and athetosis in an elderly patient with Alzheimer's disease.
    Tanaka M; Yokode M; Kita T; Matsubayashi K
    J Am Geriatr Soc; 2003 Jun; 51(6):889-90. PubMed ID: 12757588
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dementia of trisomy 21. Improvement with donepezil].
    Schill D
    Med Monatsschr Pharm; 2005 Oct; 28(10):371-2. PubMed ID: 16245462
    [No Abstract]   [Full Text] [Related]  

  • 7. Unsafe prescription medication switching recommendations.
    Subbiah P; Schwam EM
    Clin Ther; 2001 Dec; 23(12):2050-5. PubMed ID: 11813938
    [No Abstract]   [Full Text] [Related]  

  • 8. Donepezil also effective in the treatment of Tourette's syndrome?
    Niederhofer H
    Mov Disord; 2006 Nov; 21(11):2027. PubMed ID: 16986157
    [No Abstract]   [Full Text] [Related]  

  • 9. Urinary incontinence: an unrecognised adverse effect with donepezil.
    Hashimoto M; Imamura T; Tanimukai S; Kazui H; Mori E
    Lancet; 2000 Aug; 356(9229):568. PubMed ID: 10950240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open-label study of donepezil in chronic poststroke aphasia.
    Berthier ML; Hinojosa J; Martín Mdel C; Fernández I
    Neurology; 2003 Apr; 60(7):1218-9. PubMed ID: 12682346
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug-induced lupus erythematosus associated with donepezil: a case report.
    Manzo C; Putignano S
    Age Ageing; 2015 Nov; 44(6):1062-3. PubMed ID: 26420637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donepezil-induced nightmares in mild cognitive impairment.
    Kitabayashi Y; Ueda H; Tsuchida H; Yamashita T; Narumoto J; Fukui K
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):123-4. PubMed ID: 16472374
    [No Abstract]   [Full Text] [Related]  

  • 13. [Post-marketing observational study of donepezil].
    Ibach B
    Krankenpfl J; 2005; 43(1-3):25. PubMed ID: 15912820
    [No Abstract]   [Full Text] [Related]  

  • 14. How many patients complete an adequate trial of donepezil?
    Roe CM; Anderson MJ; Spivack B
    Alzheimer Dis Assoc Disord; 2002; 16(1):49-51. PubMed ID: 11882749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination treatment with guanfacine extended release and blonanserin for Tourette's syndrome comorbid with attention deficit hyperactivity disorder.
    Kawabe K; Horiuchi F; Ueno SI
    Psychiatry Clin Neurosci; 2019 Dec; 73(12):762-763. PubMed ID: 31588606
    [No Abstract]   [Full Text] [Related]  

  • 16. Adjunctive donepezil in attention deficit hyperactivity disorder youth: case series.
    Wilens TE; Biederman J; Wong J; Spencer TJ; Prince JB
    J Child Adolesc Psychopharmacol; 2000; 10(3):217-22. PubMed ID: 11052411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to "Results, rhetoric, and randomized trials: the case of donepezil".
    Lisi D
    J Am Geriatr Soc; 2009 Jul; 57(7):1317-8; author reply 1318. PubMed ID: 19570171
    [No Abstract]   [Full Text] [Related]  

  • 18. How the FDA forgot the evidence: the case of donepezil 23 mg.
    Schwartz LM; Woloshin S
    BMJ; 2012 Mar; 344():e1086. PubMed ID: 22442352
    [No Abstract]   [Full Text] [Related]  

  • 19. Effectiveness and safety of donepezil in boys with fragile x syndrome: a double-blind, randomized, controlled pilot study.
    Sahu JK; Gulati S; Sapra S; Arya R; Chauhan S; Chowdhury MR; Gupta N; Kabra M; Gupta YK; Dwivedi SN; Kalra V
    J Child Neurol; 2013 May; 28(5):570-5. PubMed ID: 22752489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapeutic challenges in treatment of a child with "the triad" of obsessive compulsive disorder, attention-deficit/hyperactivity disorder and Tourette's disorder.
    Rice T; Coffey B
    J Child Adolesc Psychopharmacol; 2015 Mar; 25(2):176-9. PubMed ID: 25782100
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.